1437 results
Multiple Myeloma - Management Algorithms
 - Treatment Initiation
 - Frontline Treatment
 - First Relapse
 - Second
Algorithms - Treatment ... - Frontline Treatment ... - First Relapse ... Second or Higher Relapse ... #relapse #initiation
Treatment of giant cell arteritis (GCA)

1st Line Strategy - GC 0.7 mg/kg/day, except for:
 • Aortitis
Treatment of giant ... necrosis, stroke) Relapses ... • 1st relapse: Incr ... mg/jd • 2nd relapse ... arteritis #GCA #Treatment
Initial treatment of renal bone disease and cinacalcet for secondary hyperparathyroidism
Phosphate binders reduce hyperphosphataemia and hyperparathyroidism.
Initial treatment ... the first-line treatments ... inhibits PTH release
Global Alliance algorithm to improve outcomes in acne.
†With small nodules (>0.5–1 cm).
‡Consider physical removal of comedones.
§Second
course in case of relapse ... PrimaryCare #Acne #Treatment
Metformin - First Line Treatment for Diabetes Type 2
• Start with initial dose of 500 mg
Metformin - First Line Treatment ... Consider extended-release ... • Try extended-release
IgG4-Related Disease
Clinical history:  Man, 60 years, multiorgan involvement, unique or multiple inflammatory pseudotumor
4 phenotypes:
 •
with response to treatment ... and relapse No ... IgG4+ cells" Treatment ... 0.6 mg/kg/day) - Relapse ... phenotypes #workup #treatment
Autoimmune Hemolytic Anemia (AIHA) Treatment
Warm AIHA:
1) Steroids - 1-2 mg/kg prednisone daily
   • Until
Anemia (AIHA) Treatment ... severe disease If relapse ... #Anemia #AIHA #Treatment
FDA-Approved 1st line Medications for Tobacco Cessation Treatment

Nicotine patch, Nicotine lozenge, Nicotine gum, Nicotine inhaler, Nicotine
Tobacco Cessation Treatment ... Bupropion sustained release
Lymphomas and Lymphoproliferative Disorders - Differential Diagnosis Algorithm
Hodgkin Lymphoma ~40% - Characteristic For Reed-Sternberg (RS) Cells
Responsive to Treatment ... growth, response to treatment ... and relapse
Babesiosis - Diagnosis and Management Summary 
Disease: Release of merozoites from erythrocytes and associated loss of
Summary Disease: Release ... Treatment: • Immunocompetent ... Patient with risk of relapse ... to 2 weeks • Relapse